Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy.
about
Treatment of profound thrombocytopenia in a patient with Gaucher disease type 1: Is there a role for substrate reduction therapy.
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Treatment of profound thromboc ...... r substrate reduction therapy.
@ast
Treatment of profound thromboc ...... r substrate reduction therapy.
@en
type
label
Treatment of profound thromboc ...... r substrate reduction therapy.
@ast
Treatment of profound thromboc ...... r substrate reduction therapy.
@en
prefLabel
Treatment of profound thromboc ...... r substrate reduction therapy.
@ast
Treatment of profound thromboc ...... r substrate reduction therapy.
@en
P2093
P2860
P1476
Treatment of profound thromboc ...... r substrate reduction therapy.
@en
P2093
Christine I Ha
Heidi Cope
Mugdha Rairikar
Priya S Kishnani
Stephanie DeArmey
P2860
P356
10.1016/J.YMGMR.2017.06.003
P577
2017-06-22T00:00:00Z